BRD2 and ovarian cancer: If so, it may be also relevant for the outcome of tumours because, like in the ovary and ovarian cancers, FSHR may mediate the stimulatory effect of FSH on cell proliferation and angiogenesis [12,13] and the inhibitory effect on apoptosis [14].